YUHAN CORPORATION Logo

YUHAN CORPORATION

A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.

000100 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 동작구 노량진로 74, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Yuhan Corporation, established in 1926, is a leading South Korean pharmaceutical and chemical company. The firm is primarily engaged in the research, development, manufacturing, and sale of a diverse portfolio of products. Its core business segments include Primary & Specialty care, featuring prescription drugs such as the anticancer treatment Lecraza; dietary supplements; household and animal care products; and the contract manufacturing of active pharmaceutical ingredients (APIs). As a pioneering entity in Korea's pharmaceutical sector, Yuhan Corporation is committed to innovation through its advanced R&D capabilities and manufacturing facilities, while also upholding a strong tradition of social responsibility.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for YUHAN CORPORATION and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.2 KB
2025-09-02 00:00
Transaction in Own Shares
자기주식취득결과보고서
Korean 35.6 KB
2025-08-27 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 7.7 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 72.8 KB
2025-08-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-20 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 7.7 KB
2025-08-18 00:00
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
Korean 19.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 5.3 MB
2025-08-01 00:00
Regulatory News Service
신탁계약해지결과보고서
Korean 20.8 KB
2025-07-30 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.5 KB
2025-07-30 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 28.6 KB
2025-07-29 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.0 KB
2025-07-01 00:00
Transaction in Own Shares
주요사항보고서(자기주식취득결정)
Korean 34.0 KB
2025-06-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-06-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB

Automate Your Workflow. Get a real-time feed of all YUHAN CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for YUHAN CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SEOUL PHARMA CO.,LTD Logo
Develops pharmaceuticals with innovative Orally Disintegrating Film (ODF) tech for global markets.
South Korea 018680
SEYİTLER KİMYA SANAYİ A.Ş. Logo
Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.
Türkiye SEYKM
Shaperon Inc. Logo
Develops inflammasome inhibitors & nanobodies for inflammatory diseases and cancer.
South Korea 378800
Shedir Pharma Group Logo
Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.
Italy SHE
SHIELD THERAPEUTICS PLC Logo
Commercializing a novel oral therapy for adults with iron deficiency.
United Kingdom STX
SHINPOONG PHARMACEUTICAL CO.,LTD Logo
R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.
South Korea 019170
Shionogi & Co.,Ltd. Logo
A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.
Japan 4507
Siegfried Holding AG Logo
Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.
Switzerland SFZN
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
South Korea 215600
SK biopharmaceuticals Co., Ltd. Logo
Develops and commercializes CNS and oncology therapies for global markets, focusing on the U.S.
South Korea 326030

Talk to a Data Expert

Have a question? We'll get back to you promptly.